Keywords: Aβ1-42; 42-amino acid-long Aβ peptide; AD; Alzheimer's disease; ADAPT; Alzheimer's Disease Anti-Inflammatory Prevention Trial; ADAS-Cog; Alzheimer's Disease Assessment Scale-Cognitive Subscale; ADCS-ADL; Alzheimer's Disease Cooperative Study Activ
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Microglia; Stress; Alzheimer's disease; Neurodegeneration; Neuroinflammation; Synaptic remodeling; Microglial phenotypes; Dark microglia; Aβ; Amyloid beta; ABCA7; ATP-binding cassette transporter A7; AD; Alzheimer's disease; APOE; Apolipoprotein E; APP;
Keywords: CR1; TOMM40; BIN1; CD33; Alzheimer's disease; Canadian; Cohorts;
The first report of siglec-3/CD33 gene in a teleost (rock bream, Oplegnathus fasciatus): An analysis of its spatial expression during stimulation to red seabream iridovirus (RSIV) and two bacterial pathogens
Keywords: CD33; Siglec; Rock bream; Innate immunity; Lectin;
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells
Keywords: Myelodysplastic syndromes; Flow cytometry; Ogata score; CD33; CD34; Side scatter;
Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome
Keywords: CD33; immune infiltrate; macrophages; Merkel cell carcinoma; myeloid cells; PD-L1; AJCC; American Joint Committee on Cancer; CI; confidence interval; FFPE; formalin-fixed paraffin-embedded; HLA-DR; human leukocyte antigen-DR; HR; hazard ratio; MCC; Merk
Featured ArticleInteraction between variants in CLU and MS4A4E modulates Alzheimer's disease risk
Keywords: Alzheimer's disease; Epistasis; MS4A4E; CLU; CD33; Meta-analysis; ADGC; ADNI;
Molecular and functional characterization of porcine Siglec-3/CD33 and analysis of its expression in blood and tissues
Keywords: Siglec-3; CD33; Monoclonal antibody; Swine; Myeloid cells; MonocyteBMDC, bone marrow-derived dendritic cell; CpG ODN, synthetic oligonucleotide with unmethylated CpG dinucleotides; GFP, green fluorescence protein; HRP, horseradish peroxidase; ITIM motif,
Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations
Keywords: Dementia; Alzheimer's disease; Polymorphism; CD33; MS4A; Genetic association;
Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients
Keywords: Alzheimer's disease; CD33; PBMCs; Expression; Biomarker
The past and future of CD33 as therapeutic target in acute myeloid leukemia
Keywords: Acute myeloid leukemia; Antibody; Antibody-drug conjugate; Bispecific antibody; BiTE; CD33; Chimeric antigen receptor; Gemtuzumab ozogamicin; Immunotherapy; Radioimmunoconjugate
Featured ArticleAssociation of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population
Keywords: Alzheimer's disease; Polymorphism; MS4A; CD33; Genomewide association studies;
Are immunoconjugates approaching “standard of care” in AML?
Keywords: 225Actinium; acute myeloid leukemia; acute promyelocytic leukemia; AML; antigen; antibody; APL; brentuximab; CD33; CD30; CD45; gentuzumab ozogamicin; immunoconjugates; SGN-CD331
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses
Keywords: Retargeting; Bispecific antibodies; Tumor immunology; La antigen; CD33
Unexpected recombinations in single chain bispecific anti-CD3–anti-CD33 antibodies can be avoided by a novel linker module
Keywords: Redirecting T cells; Bispecific antibodies; AML; CD33; Helical linker
Monoclonal antibodies in the treatment of hematologic malignancy
Keywords: MAb; Leukemia; Lymphoma; Rituximab; Ofatumamab; Alemtuzumab; Gemtuzumab; Lintuzumab; CD20; CD33; CD44; CD52; CD123
CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease
Keywords: Immunoglobulin superfamily; Inhibitory receptors; Innate immunity; Siglecs; Sialic acid; CD33
Radioimmunotherapeutic approaches for leukemia: the past, present and future
Keywords: CD33; CD45; CD66; leukemia; radioimmunotherapy; radiolabeled antibody
Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia
Keywords: Myeloid markers; Childhood acute lymphoblastic leukemia; CD13; CD33; CD15;
Contrasting antigenic maturation patterns in M0–M2 versus M3 acute myeloid leukemias
Keywords: Acute myelogenous leukemia; Flow cytometry; M0–M2 AML; M3 AML; CD13; CD33; CD34; HLA-DR
Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors
Keywords: AML; Surface expression; Endocytosis; CD33
Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34â AML patients express CD33
Keywords: Ab therapy; AML; CD33; CD34; stem cells;
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute mye
Keywords: Mylotarg; Intermediate-dose cytarabine; Mitoxantrone; CD33; Relapsed/refractory AML;
Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor
Keywords: NK cells; CD33; Chimeric receptor; Leukemia; Targeting; Gene transfer;
Expression of an anti-CD33 single-chain antibody by Pichia pastoris
Keywords: Abs; antibodies; AML; acute myeloid leukaemia; AOX; alcohol oxidase; BMGY; buffered glycerol complex medium; BMMY; buffered methanol complex medium; CFU-GEMM; colony forming units for granulocytes, erythrocytes, monocytes and megakaryocytes; CFU-GM, BFU-E